Biosimilar Utilization and Inventory Management

Opinion
Video

Sophia Humphreys, PharmD, MHA, BCBBS, discusses biosimilar utilization and inventory management.

Video content above is prompted by the following:

  • How has the introduction of biosimilars affected the biologic landscape at specialty pharmacies, including the disease states treated and trends in utilization?
  • What strategies, including the “just in time” inventory model, can specialty pharmacies employ to effectively manage their high-cost biologic and biosimilar inventory given the challenges of limited shelf space?
Recent Videos
Related Content